Staging systems for hepatocellular carcinoma: Current status and future perspectives

doi:10.4254/wjh.v7.i3.406

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10865)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-20) series.

Item

Count

PDF

747

WORD

348

HTML

7310

Figures (1-3)

216

Tables (1-20)

124

Sum=8745

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1026

Download

1094

Sum=2120

Mar 27, 2015 (publication date) through Apr 17, 2024

Times Cited of This Article

Times Cited (102)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. Mar 27, 2015; 7(3): 406-424
Published online Mar 27, 2015. doi: 10.4254/wjh.v7.i3.406

Table 18 Alpha-fetoprotein staging

AFP (ng/mL)	Stage
< 10	N (normal)
10-150	A
150-500	B
> 500	C

AFP: Alpha-fetoprotein.

Citation: Kinoshita A, Onoda H, Fushiya N, Koike K, Nishino H, Tajiri H. Staging systems for hepatocellular carcinoma: Current status and future perspectives. World J Hepatol 2015; 7(3): 406-424
URL: https://www.wjgnet.com/1948-5182/full/v7/i3/406.htm
DOI: https://dx.doi.org/10.4254/wjh.v7.i3.406